0
Sign In  | Subscribe
17 December 2002, Vol 137, No. 12>
Summaries for Patients | 17 December 2002

Liver Disease in Persons with Asymptomatic Hepatitis C Virus Infection FREE

[+] Article and Author Information

The summary below is from the full report titled “Prevalence of Liver Disease in a Population of Asymptomatic Persons with Hepatitis C Virus Infection.” It is in the 17 December 2002 issue of Annals of Internal Medicine (volume 137, pages 961-964). The authors are A Alberti, F Noventa, L Benvegnù, S Boccato, and A Gatta.


Ann Intern Med. 2002;137(12):I-36. doi:10.7326/0003-4819-137-12-200212170-00004
Text Size: A A A

What is the problem and what is known about it so far?

Hepatitis C virus (HCV) can cause severe liver disease. It is transmitted when an uninfected person is exposed to the blood of someone with the infection. Before it became possible to test donated blood for HCV, many persons became infected when receiving blood transfusions. Other ways to spread HCV include illicit drug use; exposure to blood in the workplace (such as occurs with health care workers, firefighters, and police officers); and such procedures as body piercing, tattooing, or dental work with nonsterile tools. However, the source of infection is unknown in many persons. Although some people with HCV infection become severely ill (they almost die or need liver transplants), many remain healthy and have no symptoms. Among persons who have HCV infection with no symptoms, it is unclear how many also have damage to the liver with no symptoms (“silent” liver damage). Knowing the extent to which silent liver damage exists in people with asymptomatic HCV infection will help determine how aggressive doctors need to be when examining healthy people for HCV infection.

Why did the researchers do this particular study?

To find out how often persons with HCV but no symptoms have liver damage.

Who was studied?

4820 healthy employees and relatives of employees of a company in northern Italy who were participating in a study of risk factors for heart disease.

How was the study done?

The researchers tested the blood of the participants for HCV by first using a screening test and then using a test that measures levels of the virus in the blood. In persons whose blood tested positive for the virus, another test was used to measure alanine aminotransferase (ALT), a substance that increases in people with liver disease. Researchers also took a small piece of liver to look at under the microscope (liver biopsy) in persons who agreed to have this procedure.

What did the researchers find?

Of the 4820 participants, 85 tested positive for HCV in their blood. About half of these 85 people had normal ALT levels, and half had elevated ALT levels. Abnormalities were present on liver biopsy in about 20% of persons with normal ALT levels and about 60% of persons with elevated ALT levels. The older a person was, the more likely he or she was to have HCV infection and, if the person had the infection, the more likely he or she was to have liver disease.

What were the limitations of the study?

This study took place in Italy, and the results may not apply to other geographic areas. The researchers did not follow participants to see whether they actually became ill.

What are the implications of the study?

Persons with HCV infection but no symptoms can have liver damage. People who are older and who have elevated ALT levels are more likely to have liver damage than are those who are younger or who have normal ALT levels.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Compression-Only CPR: Pushing the Science Forward
Cone
AAM 2010;304:1493-1495.
All you need to read in the other general jounals
BMJ 2010;341:c5893-c1494.

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Advertisement

Related Content

Customize your page view by dragging & repositioning the boxes below.

In the Clinic
Hepatitis C
Ann Intern Med. 2012;157(11):ITC6-1.
Hepatitis C
Ann Intern Med. 2008;148(11):ITC6-1.
Topic Collections
PubMed Articles
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir.
Antiviral therapy Issue date: 2013 May 3
Moderate/heavy alcohol use and HCV infection among injection drug users in two Russian cities.
Drug and alcohol dependence Issue date: 2013 May 1

Annals of Internal Medicine

Other Resources

Copyright © 2013 The American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Buy This Article

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Register Now for a free account
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)